Cas Medical Systems Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Cas Medical Systems Inc (CASM) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Cas Medical Systems Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 22M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+5.9% annualized vs trailing 12 months).
- Peer revenue share: Cas Medical Systems Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CASM Sales vs. its Competitors, Q1 2018
Cas Medical Systems Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Medical Equipment & Supplies industry grew revenue 14.5% year over year, combined, vs 13.3% for Cas Medical Systems Inc. Cas Medical Systems Inc's share of combined industry revenue moved from 0.01% to 0.00%, a gain of 0.00 percentage points.
Cas Medical Systems Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Cas Medical Systems Inc | No | Yes | Yes | No |
| High-Confidence Competitors (29) | ||||
| Similar Growth & Profitability (8) | 0.00 % (0 of 8) | 87.50 % (7 of 8) | 50.00 % (4 of 8) | 33.30 % (2 of 6) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CASM Stock Performance relative to its Competitors
CASM Stock Performance relative to High-Confidence Competitors
CASM Stock Performance relative to Similar Growth & Profitability Competitors
Cas Medical Systems Inc's Competitors Named by the Company
Competitive relationships identified from Cas Medical Systems Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Avinger Inc | Company report | 85% |
| Integra Lifesciences Holdings Corp | Company report | 85% |
| Co diagnostics Inc | Company report | 85% |
| Quidelortho Corp | Company report | 85% |
| Angiodynamics Inc | Company report | 85% |
| Solventum Corporation | Company report | 85% |
| Nautilus Biotechnology Inc | Company report | 85% |
| Retractable Technologies Inc | Company report | 85% |
| Lemaitre Vascular Inc | Company report | 85% |
| Koninklijke Philips Nv | Company report | 85% |
| United Health Products Inc | Company report | 85% |
| Orchestra Biomed Holdings Inc | Company report | 85% |
| Sanara Medtech Inc | Company report | 85% |
| Volitionrx Limited | Company report | 85% |
| Alcon inc | Company report | 85% |
| Tela Bio Inc | Company report | 85% |
| Sharps Technology Inc | Company report | 85% |
| Cytek Biosciences Inc | Company report | 85% |
| AWH | Company report | 85% |
| Aspira Women s Health inc | Company report | 85% |
| T2 Biosystems Inc | Company report | 85% |
| Inari Medical Inc | Company report | 85% |
| Accelerate Diagnostics Inc | Company report | 85% |
| 10x Genomics Inc | Company report | 85% |
| Icu Medical Inc | Company report | 85% |
| Inspira Technologies Oxy B H N Ltd | Company report | 85% |
| OPGN | Company report | 85% |
| Bard | Company report | 85% |
| Bio techne Corp | Company report | 85% |
| Capforce Inc | Company report | 85% |
| Baxter International Inc | Company report | 85% |
| Procedural Solutions | Company report | 85% |
| Medical Systems | Company report | 85% |
| Abbott Laboratories | Company report | 85% |
| Boston Scientific Corporation | Company report | 85% |
| Guided Therapeutics Inc | Company report | 85% |
| Talis Biomedical Corporation | Company report | 85% |
| Teleflex Incorporated | Company report | 85% |
| Thermo Fisher Scientific Inc | Company report | 85% |
| Stryker Corp | Company report | 85% |
| Orasure Technologies Inc | Company report | 85% |
| Motus Gi Holdings Inc | Company report | 85% |
| Haemonetics Corporation | Company report | 85% |
| Johnson and Johnson | Company report | 85% |
| Utah Medical Products Inc | Company report | 85% |
| Escalon Medical Corp | Company report | 85% |
| Cue Health Inc | Company report | 85% |
| Embecta Corp | Company report | 85% |
| Medtronic Plc | Company report | 85% |
| Standard Biotools Inc | Company report | 85% |
| Reshape Lifesciences Inc | Company report | 85% |
| Tactile Systems Technology Inc | Company report | 85% |
| Hologic Inc | Company report | 85% |
| 3m Company | Company report | 85% |
| Cutera Inc | Company report | 85% |
| Iridex Corp | Company report | 85% |
| Koru Medical Systems Inc | Company report | 85% |
| Merit Medical Systems Inc | Company report | 85% |
| Danaher Corporation | Company report | 85% |
| Edap Tms Sa | Company report | 85% |
Company report basis, confidence, active dates and source counts for Cas Medical Systems Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.